Adjuvant chemotherapy is not associated with improved survival for all high‐risk factors in stage II colon cancer

Adjuvant chemotherapy is not associated with improved survival for all high‐risk factors in stage II colon cancer

Adjuvant chemotherapy can be considered in high‐risk stage II colon cancer comprising pT4, poor/undifferentiated grade, vascular invasion, emergency surgery and/or

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2016-07, Vol.139 (1), p.187-193
Hauptverfasser: Verhoeff, S.R., van Erning, F.N., Lemmens, V.E.P.P., de Wilt, J.H.W., Pruijt, J.F.M.
Format: Artikel
Sprache:eng
Schlagworte:
Adenocarcinoma - drug therapy
Adenocarcinoma - epidemiology
Adenocarcinoma - pathology
adjuvant chemotherapy
Adolescent
Adult
Aged
Aged, 80 and over
Cancer
Chemotherapy
Chemotherapy, Adjuvant
Clinical Trials as Topic
Colonic Neoplasms - drug therapy
Colonic Neoplasms - epidemiology
Colonic Neoplasms - pathology
Colorectal cancer
Disease-Free Survival
Drug dosages
Female
high‐risk stage II colon cancer
Humans
Kaplan-Meier Estimate
Lymph Nodes - pathology
Male
Medical research
Middle Aged
Mortality
Neoplasm Staging
overall survival
Patients
Prognosis
pT4
relative survival
Risk Factors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Adjuvant chemotherapy can be considered in high‐risk stage II colon cancer comprising pT4, poor/undifferentiated grade, vascular invasion, emergency surgery and/or
ISSN:0020-7136
1097-0215
DOI:10.1002/ijc.30053